{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:10Z","timestamp":1788873190744,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ekir.2020.08.001","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T08:22:13Z","timestamp":1597393333000},"page":"2021-2031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity"],"prefix":"10.1016","volume":"5","author":[{"given":"Anatilde M.","family":"Gonzalez Guerrico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lopez-Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Bobart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Shevell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.08.001_bib1","unstructured":"United States Renal Data System. 2017 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017. Available at: www.usrds.org. Accessed October 22, 2020."},{"key":"10.1016\/j.ekir.2020.08.001_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2020.08.001_bib4","article-title":"Circulating dendritic cells in pediatric patients with nephrotic syndrome","volume":"9","author":"El-Hakim Ihab","year":"2011","journal-title":"Egypt J Pediatr Allergy Immunol"},{"key":"10.1016\/j.ekir.2020.08.001_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T\u00a0regulatory cell function in idiopathic minimal lesion nephrotic syndrome","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cyto.2014.12.028","article-title":"Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in childhood nephrotic syndrome: a longitudinal study","volume":"72","author":"Prasad","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ekir.2020.08.001_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138343","article-title":"A\u00a0pilot study of IL2 in drug-resistant idiopathic nephrotic syndrome","volume":"10","author":"Bonanni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.08.001_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ekir.2020.08.001_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10157-017-1489-3","article-title":"Interaction of CD80 with Neph1: a potential mechanism of podocyte injury","volume":"22","author":"Khullar","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2020.08.001_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.kint.2016.06.022","article-title":"The costimulatory receptor B7-1 is not induced in injured podocytes","volume":"90","author":"Baye","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.08.001_bib13","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1681\/ASN.2015091002","article-title":"B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS","volume":"27","author":"Delville","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000446324","article-title":"Another piece of the puzzle of podocyte B7-1 expression: lupus nephritis","volume":"133","author":"Novelli","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2020.08.001_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00467-014-2957-6","article-title":"Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis","volume":"30","author":"Garin","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7-1 in diabetic nephropathy","volume":"25","author":"Fiorina","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib17","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1\u2013positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.08.001_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/j.ajkd.2014.07.023","article-title":"B7-1 immunostaining in proteinuric kidney disease","volume":"64","author":"Larsen","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.08.001_bib19","doi-asserted-by":"crossref","first-page":"F335","DOI":"10.1152\/ajprenal.00510.2015","article-title":"Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?","volume":"310","author":"Novelli","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ekir.2020.08.001_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2015030266","article-title":"B7-1 is not induced in podocytes of human and experimental diabetic nephropathy","volume":"27","author":"Gagliardini","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib21","series-title":"Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse","author":"Cara-Fuentes","year":"2020"},{"key":"10.1016\/j.ekir.2020.08.001_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1681\/ASN.2015080947","article-title":"Podocyte expression of B7-1\/CD80: is it a reliable biomarker for the treatment of proteinuric kidney diseases with abatacept?","volume":"27","author":"Salant","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1242\/dmm.023440","article-title":"TLR-mediated albuminuria needs TNFalpha-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice","volume":"9","author":"Jain","year":"2016","journal-title":"Dis Models Mech"},{"key":"10.1016\/j.ekir.2020.08.001_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ekir.2020.08.001_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ekir.2017.08.013","article-title":"Randomized clinical trial design to assess abatacept in resistant nephrotic syndrome","volume":"3","author":"Trachtman","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.08.001_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.08.001_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00467-014-2915-3","article-title":"Urinary CD80 levels as a diagnostic biomarker of minimal change disease","volume":"30","author":"Ling","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-017-3613-8","article-title":"Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome","volume":"32","author":"Mishra","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib29","doi-asserted-by":"crossref","first-page":"17322","DOI":"10.1038\/s41598-018-35798-2","article-title":"The utility of urinary CD80 as a diagnostic marker in patients with renal diseases","volume":"8","author":"Minamikawa","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.08.001_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5414\/CN109290","article-title":"Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept","volume":"89","author":"Dado","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00467-018-3885-7","article-title":"Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome","volume":"33","author":"Ling","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12882-015-0185-3","article-title":"Strategy and rationale for urine collection protocols employed in the NEPTUNE study","volume":"16","author":"Hogan","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach","volume":"29","author":"De Vriese","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.08.001_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/art.38260","article-title":"Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study","volume":"66","author":"Furie","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2020.08.001_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ekir.2019.05.1155","article-title":"Abatacept in steroid-dependent minimal change disease and CD80-uria","volume":"4","author":"Isom","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.08.001_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ekir.2017.08.013","article-title":"Randomized clinical trial design to assess abatacept in resistant nephrotic syndrome","volume":"3","author":"Trachtman","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.08.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000454947","article-title":"Unsuccessful treatment with abatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"7","author":"Kristensen","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"key":"10.1016\/j.ekir.2020.08.001_bib38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/tri.12574","article-title":"Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"28","author":"Grellier","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2020.08.001_bib39","article-title":"Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis","volume":"2016","author":"Jayaraman","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ekir.2020.08.001_bib40","first-page":"456","article-title":"Recurrent focal segmental glomerulosclerosis and abatacept: case report","volume":"14","author":"Alkandari","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.ekir.2020.08.001_bib41","first-page":"107","article-title":"Urinary CD80 as a replacement for renal biopsy for diagnosis of pediatric minimal change disease","volume":"12","author":"Ahmed","year":"2018","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.08.001_bib42","first-page":"727","article-title":"CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation","volume":"33","author":"Cara-Fuentes","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.ekir.2020.08.001_bib43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/keh663","article-title":"Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ekir.2020.08.001_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126136","article-title":"B\u00a0lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes","volume":"4","author":"Linsley","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ekir.2020.08.001_bib45","first-page":"7457269","article-title":"Role of adaptive and innate immunity in type 2 diabetes mellitus","volume":"2018","author":"Zhou","year":"2018","journal-title":"J\u00a0Diabetes Res"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492031439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492031439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:33:54Z","timestamp":1762832034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802492031439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S246802492031439X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.08.001","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}